The Analyst Verdict: Vericel In The Eyes Of 7 Experts
Portfolio Pulse from Benzinga Insights
In the past three months, 7 analysts have rated Vericel (NASDAQ:VCEL), with most being bullish. The average 12-month price target is $57.43, up from $55.60. Analysts have adjusted their ratings and price targets, reflecting positive sentiment towards Vericel's market position and financial performance.
August 27, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vericel has received predominantly bullish ratings from analysts, with an average price target increase to $57.43. This reflects positive sentiment towards the company's market position and financial performance.
The majority of analysts have rated Vericel as bullish, with an increase in the average price target. This suggests a positive outlook on the company's future performance, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100